ZimVie (ZIMV) to Release Earnings on Wednesday

ZimVie (NASDAQ:ZIMV) is set to release its earnings data after the market closes on Wednesday, October 30th. ZimVie has set its FY 2024 guidance at 0.550-0.700 EPS.Investors interested in registering for the company’s conference call can do so using this link.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.04). ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. The business had revenue of $116.81 million during the quarter. During the same period last year, the business earned $0.17 EPS.

ZimVie Stock Performance

Shares of NASDAQ:ZIMV opened at $14.31 on Wednesday. ZimVie has a 12-month low of $6.52 and a 12-month high of $22.40. The company’s 50 day moving average price is $16.37 and its two-hundred day moving average price is $16.97. The firm has a market cap of $394.53 million, a PE ratio of -1.08 and a beta of 2.12. The company has a quick ratio of 1.43, a current ratio of 1.94 and a debt-to-equity ratio of 0.62.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC raised their price objective on ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd.

Insider Buying and Selling at ZimVie

In related news, major shareholder Camber Capital Management Lp sold 525,000 shares of the stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the sale, the insider now owns 2,725,000 shares in the company, valued at approximately $48,259,750. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.01% of the company’s stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.